254 related articles for article (PubMed ID: 12901515)
1. Heat shock protein gp96 and cancer immunotherapy.
Peibin Y; Shude Y; Changzhi H
Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
[TBL] [Abstract][Full Text] [Related]
2. Heat shock protein-peptide complexes for use in vaccines.
Heike M; Noll B; Meyer zum Büschenfelde KH
J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
[TBL] [Abstract][Full Text] [Related]
3. Association of peptides with heat shock protein gp96 occurs in vivo and not after cell lysis.
Ménoret A; Peng P; Srivastava PK
Biochem Biophys Res Commun; 1999 Sep; 262(3):813-8. PubMed ID: 10471407
[TBL] [Abstract][Full Text] [Related]
4. Secreted heat shock protein gp96-Ig: an innovative vaccine approach.
Strbo N; Podack ER
Am J Reprod Immunol; 2008 May; 59(5):407-16. PubMed ID: 18405311
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic tumor-cell-based vaccines secreting endoplasmic reticulum chaperone gp96.
Podack ER; Raez LE
Expert Opin Biol Ther; 2007 Nov; 7(11):1679-88. PubMed ID: 17961091
[TBL] [Abstract][Full Text] [Related]
6. Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited.
Randazzo M; Terness P; Opelz G; Kleist C
Int J Cancer; 2012 May; 130(10):2219-31. PubMed ID: 22052568
[TBL] [Abstract][Full Text] [Related]
7. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
[TBL] [Abstract][Full Text] [Related]
8. Preventive and therapeutic effect of tumor derived heat shock protein, gp96, in an experimental prostate cancer model.
Yedavelli SP; Guo L; Daou ME; Srivastava PK; Mittelman A; Tiwari RK
Int J Mol Med; 1999 Sep; 4(3):243-8. PubMed ID: 10425272
[TBL] [Abstract][Full Text] [Related]
9. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
Li Z; Srivastava PK
EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
[TBL] [Abstract][Full Text] [Related]
10. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.
Arnold D; Wahl C; Faath S; Rammensee HG; Schild H
J Exp Med; 1997 Aug; 186(3):461-6. PubMed ID: 9236199
[TBL] [Abstract][Full Text] [Related]
11. Biophysical analysis of the endoplasmic reticulum-resident chaperone/heat shock protein gp96/GRP94 and its complex with peptide antigen.
Linderoth NA; Simon MN; Rodionova NA; Cadene M; Laws WR; Chait BT; Sastry S
Biochemistry; 2001 Feb; 40(5):1483-95. PubMed ID: 11170476
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor gene-transduced tumor cells combined with tumor-derived gp96 inhibit tumor growth in mice.
Kojima T; Yamazaki K; Tamura Y; Ogura S; Tani K; Konishi J; Shinagawa N; Kinoshita I; Hizawa N; Yamaguchi E; Dosaka-Akita H; Nishimura M
Hum Gene Ther; 2003 May; 14(8):715-28. PubMed ID: 12804136
[TBL] [Abstract][Full Text] [Related]
13. Heat shock proteins and cancer immunotherapy.
Wang XY; Kaneko Y; Repasky E; Subjeck JR
Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
[TBL] [Abstract][Full Text] [Related]
14. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
15. Immunization of cancer patients with autologous cancer-derived heat shock protein gp96 preparations: a pilot study.
Janetzki S; Palla D; Rosenhauer V; Lochs H; Lewis JJ; Srivastava PK
Int J Cancer; 2000 Oct; 88(2):232-8. PubMed ID: 11004674
[TBL] [Abstract][Full Text] [Related]
16. CD91: a receptor for heat shock protein gp96.
Binder RJ; Han DK; Srivastava PK
Nat Immunol; 2000 Aug; 1(2):151-5. PubMed ID: 11248808
[TBL] [Abstract][Full Text] [Related]
17. HSPPC-96: a personalised cancer vaccine.
Caudill MM; Li Z
Expert Opin Biol Ther; 2001 May; 1(3):539-47. PubMed ID: 11727524
[TBL] [Abstract][Full Text] [Related]
18. Differences in glycosylation patterns of heat shock protein, gp96: implications for prostate cancer prevention.
Suriano R; Ghosh SK; Ashok BT; Mittelman A; Chen Y; Banerjee A; Tiwari RK
Cancer Res; 2005 Jul; 65(14):6466-75. PubMed ID: 16024652
[TBL] [Abstract][Full Text] [Related]
19. Evolution of the immunomodulatory role of the heat shock protein gp96.
Robert J; Cohen N; Maniero GD; Goyos A; Morales H; Gantress J
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):263-75. PubMed ID: 12887107
[TBL] [Abstract][Full Text] [Related]
20. [Immune activity of heat shock protein gp96 and its application in active immunotherapy for tumor and infectious diseases].
Xu Y; Wang S; Zhang X; Meng S
Sheng Wu Gong Cheng Xue Bao; 2012 Mar; 28(3):261-6. PubMed ID: 22712385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
